Josep M. Argimon

TL;DR: In patients with mild Covid-19, no benefit was observed with HCQ beyond the usual care and the time to complete resolution of symptoms was shortened.

TL;DR: A large improvement in skills and knowledge in EBP is noted when measured together in a total test score, compared with a small improvement in knowledge, skills, attitudes or behavior when measured alone.

TL;DR: Postexposure therapy with hydroxychloroquine did not prevent SARS-CoV-2 infection or symptomatic Covid-19 in healthy persons exposed to a PCR-positive case patient.

TL;DR: Postexposure therapy with HCQ did not prevent SARS-CoV-2 disease and infection in healthy individuals exposed to a PCR-positive Covid-19 case, and the findings do not support HCQ as postexposure prophylaxis for Covd-19.

TL;DR: Vaccination was associated with 85%-96% reduction in SARS-CoV-2 infection in all three cohorts, and bigger reductions in hospitalisations and mortality amongst nursing home residents for up to two months, and more data are needed on the long-term effects of COVID-19 vaccines.